The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Norepinephrine
Norepinephrine Bitartrate · NOREPINEPHRINE BITARTRATE 32 ug/mL · Solution · Intravenous · Long Grove Pharmaceuticals, LLC
NDC 81298-9655-03 · 10 POUCH in 1 BOX / 1 BAG in 1 POUCH / 250 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$380.00
Reported to Texas DSHS · 2026 annual filing · Long Grove Pharmaceuticals, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA214628
- TE code
- —
- Approval date
- Oct 6, 2022
- Patents / exclusivity
- 21 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11413259 | Jan 30, 2038 |
| patent | 11413259 | Jan 30, 2038 |
| patent | 11413259 | Jan 30, 2038 |
| patent | 10420735 | Jan 30, 2038 |
| patent | 10420735 | Jan 30, 2038 |
| patent | 10420735 | Jan 30, 2038 |
| patent | 10226436 | Jan 30, 2038 |
| patent | 10226436 | Jan 30, 2038 |
| patent | 10226436 | Jan 30, 2038 |
| patent | 10568850 | Jan 30, 2038 |
| patent | 12245996 | Jan 30, 2038 |
| patent | 10159657 | Jan 30, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Norepinephrine Bitartrate (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Long Grove Pharmaceuticals, LLC | NOREPINEPHRINE BITARTRATE 16 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Long Grove Pharmaceuticals, LLC | NOREPINEPHRINE BITARTRATE 32 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Long Grove Pharmaceuticals, LLC | NOREPINEPHRINE BITARTRATE 64 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | NOREPINEPHRINE BITARTRATE 1 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Norepinephrine — NDC 81298-9655-03," retrieved September 3, 2026, https://drugdashboards.com/drug/81298965503.
Free to cite with attribution — see how the data is put together.